Frontline: Surgery to remove the tumor is often considered, sometimes followed by chemotherapy or radiation to reduce ...

Lung cancer varies widely from patient to patient, and that diversity makes it hard to find effective treatments. Researchers ...

Gainor highlighted that anyone can develop lung cancer, including people who have never smoked, and addressed the stigma that ...

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...

Background Antifibrotic (AF) therapy has been shown to potentially reduce the risk of lung cancer (LC) in patients with ...

While the statistics remain stark—lung cancer is the most common type of cancer worldwide and has the highest death ...

Dr Mark Kris discusses the increasing precision of lung cancer therapies and the need for additional testing to find ...

Anktiva, also known as nogapendekin alfa inbakicept, is a new cancer therapy that boosts the immune system to target cancer ...

Despite a significant 48.8% objective response rate and breakthrough therapy status, this regulatory shift reverses years of ...

A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living with small cell lung cancer (SCLC). However, its cost raises questions about ...

When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer grows.

UF Health Cancer Institute researchers have discovered a small compound produced naturally by gut bacteria that doubled the ...